Gilead Says U.S. Government Breached HIV Research Agreements

Gilead Sciences Inc. accused the U.S. government in the Court of Federal Claims of breaching research agreements by secretly patenting HIV treatments using information shared during the company’s development of Truvada for PrEP.

The U.S. sued Gilead for infringing its HIV-treatment patents with Truvada in November in Delaware federal court. Gilead’s April 24 complaint said the U.S. government wouldn’t have received the patents if it hadn’t breached the agreements.

Gilead said it has provided the CDC “millions of dollars of pharmaceuticals—at no cost to CDC—to further the scientific community’s efforts to end the HIV epidemic.” Under a 2004 agreement, Gilead ...